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Abstract
Background: Aplasia cutis congenita (ACC), classified in nine groups, is likely to be underreported, since milder
isolated lesions in wellbeing newborns could often be undetected, and solitary lesions in the context of
polymalformative syndromes could not always be reported. Regardless of form and cause, therapeutic options have
in common the aim to restore the deficient mechanical and immunological cutaneous protection and to limit the
risk of fluid leakage or rupture of the exposed organs. We aimed to review our institutional prevalence,
comorbidities, treatment and outcome of newborns with ACC.
Methods: We conducted a retrospective study including all newborns affected by ACC and admitted at the
University Mother-Child Department from October 2010 to October 2019. Anthropometric and clinical
characteristics of ACC1 versus a non-isolated ACC group were analyzed.
Results: We encountered 37 newborns, 16 with ACC1 versus 21 with non-isolated ACC. The incidence rate of 0.1% in
ACC1 was higher than expected, while 19% of cases showed intrafamilial autosomal dominant transmission. Higher
birth weight centile, though lower than reference population, being adequate for gestational age, normal Apgar score
and euglycemia characterizing ACC1 resulted associated to a rapid tissue regeneration. Non-isolated ACC, in relation to
concomitant congenital anomalies and higher prematurity rate, showed more surgical and medical complications
along with the risk of neonatal death. Specifically, newborns with ACC4 were characterized by the frequent necessity of
abdominal wall defect repair, responsible for the occurrence of an abdominal compartment syndrome.
Conclusion: Prompt carefully assessment of the newborn with ACC in order to exclude concomitant other congenital
malformations, provides clues to the underlying pathophysiology, and to the short-term prognosis. Family should be
oriented toward identification of other family members affected by similar pathology, while obstetric history should
exclude initial multiple pregnancy with death of a co-twin, placental anomalies and drug assumption. Molecular-
genetic diagnosis and genetic counseling are integrative in individualized disease approach.
Keywords: Retrospective study, Scalp defect, Meningomyelocele, Abdominal wall defect, Junctional epidermolysis
bullosa
Background
Aplasia cutis congenita (ACC) is a clinical neonatal find-
ing of absence or defects involving the skin and encom-
passing heterogeneous disorders of various etiologies
and severity. It can occur anywhere on the body, but
most commonly presents as a small erythematous-
ulcerated or scar-like alopecic ectodermal lesion on the
scalp vertex.
The incidence of ACC is about 0.3‰ of live births [1].
Thus, ACC is likely to be underreported, since milder
isolated lesions in wellbeing newborns could often be
undetected. Moreover, solitary lesions in the context of
polymalformative syndromes could not always be
reported.
ACC may occur as an isolated cutaneous malforma-
tion (solitary or multiple defects, involving one or more
skin districts) or in association with multiple
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malformations of others organ systems. Therefore, ACC
may represent an index of suspicion to rule out develop-
mental anomalies or complex syndromes, inherited skin
fragility or destructive consequences in otherwise nor-
mally developed skin [1, 2].
The classification of ACC into nine groups on the
basis of location and pattern of the skin defect, presence
of associated abnormalities, and mode of inheritance,
has been recently updated by molecular-genetic diagno-
ses [2, 3] (Table 1). Even the non-syndromic form of
ACC1 (MIM #107600) has been found to be associated
to a gene defect (BMS1 gene) [5], resembling a riboso-
mopathy slowing skin morphogenesis by p21-mediated
cell cycle arrest. Alterations in other regulator proteins
resulting in enhanced cell migration rate and reduced
cell proliferation in ACC are described, p.e. for Adams-
Oliver syndrome [6].
Life-threatening complications must be prevented with
timely multidisciplinary support not only in case of large
lesions associated with defects in the underlying bone
and dura mater or associated with embryologic malfor-
mations (meningomyelocele, porencephaly, leptomenin-
geal angiomatosis, cranial stenosis, spinal dysraphism,
gastroschisis, omphalocele or bladder exstrophy) [2, 7].
Regardless of form and cause, therapeutic options have
in common the aim to restore the deficient mechanical
and immunological cutaneous protection and to limit
the risk of fluid leakage or rupture of the exposed organs
[7, 8]. Small lesions without exposed organs usually heal
spontaneously over a few weeks, even when the bone is
involved. Conservative treatment of larger scalp defects
includes the use of adhering or non-adhering dressings
containing hydrogel, emollients, silver or topical agents.
Newly proposed treatments as topical ozone therapy
may promote also the osteogenic potential of the bone
surrounding the defect [7]. Emergency surgical treat-
ment options in case of defect sizes > 15 cm2 include
coverage with allogenic dermis, full-thickness or split-
thickness skin grafts, cultured keratinocyte autografts,
free or local flaps, and early reconstructive cranioplasty.
Residual scars, alopecies, or contractures take advantage
by a second-surgery revision.
The prognosis for small self-healing scalp lesions is ex-
cellent. The estimated mortality rate among patients
with larger scalp ACC type 1 and 2 is high as 14% [7].
Because there are only individual reports for the other
forms, it is difficult to calculate a mortality rate or to
give an individualized prognosis. Therefore, we aimed to
review our institutional prevalence, comorbidities, treat-
ment and outcome of newborns with ACC.
Methods
After approval from our Hospital Ethic Committee, we
performed a retrospective study including all newborns
affected by ACC and admitted at the Mother-Child De-
partment of University Hospital of Palermo from Octo-
ber 2010 to October 2019. Neonatal anthropometric
data, perinatal clinical characteristics, comorbidities,
healing outcome and survival rate were collected from
charts and analyzed. Written informed parental consent
was obtained at admission for use of patient’s data.
Statistical analyses were performed by the open source
statistical R 3.04.0 software (R Development Core Team,
Vienna, Austria), and the significance was defined as p-
value < 0.05. Anthropometric and clinical characteristics
of the ACC1 versus the non-isolated ACC group were
compared using Kruskal–Wallis tests for continuous
variables, and Fisher’s exact tests for categorical
variables.
Results
We enrolled 37 newborns (15 Females/22 Males) and
identified 16 patients (43%) with ACC1 and 21 patients
with non-isolated forms (49% ACC4 and 8% ACC6).
Considering only inborn patients, the incidence rate was
0.2% of all types, and 0.1% of only ACC1, while the
prevalence in our neonatal care unit was 1.3 and 0.5%,
respectively.
Within the ACC1 group only one patient, the only
preterm < 34 weeks gestation, born from a diabetic
mother, was affected by a millimetric interventricular
septum defect that closed spontaneously during the hos-
pital stay. No patient in the ACC1 group had cerebral or
ocular malformations. The mean diameter of lesion was
3.1 ± 4 cm (range 0.3–10 cm). We encountered 19% of
cases with intrafamilial transmission, one case through
three generations, two cases through two generations.
Except for the larger defect, all lesions showed a spon-
taneous healing. The larger defect in a male newborn,
patient 1, required an emergency surgical treatment by
coverage with a dermal matrix allograft, daily occlusive
medications and ambulatory follow up. It healed within
2 months.
Array-comparative genomic hybridization (a-CGH)
analysis was conducted in two patients with large ACC1
scalp defects. In patient 1 we identified a
19q12(30173190_30286951) duplication of 113 kb
encompassing the gene C19orf12 in the GRCh37 code,
linked to neurodegeneration with brain iron accumula-
tion 4. Since no central nervous system anomalies in
proband and no neurodegenerative symptoms in rela-
tives were present, we did not proceed with further
investigations.
Patient 2 with familiar recurrence, showed multiple
duplications: 10p15.1(5462228_5896539) duplication of
434 kb encompassing NET1, CALML5, CALML3, ASB13,
GDI2, TASOR2; 10p14(7858350_8042996) duplication of
184 kb encompassing TAF3; 11q25(131110755_
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131257447) duplication of 146 kb encompassing NTM;
12q24.33(132475221_132626501) duplication of 151 kb
encompassing EP400, SNORA49, EP400NL, DDX51 in
the GRCh37 code. Since multiple duplications involved
manifold protein regulators, not described in ACC, in-
formed parents refuted to proceed with further studies.
The most frequent pathology in the non-isolated ACC
group was congenital abdominal wall defect (6 patients
with gastroschisis; 8 patients with lateral, 2 with caudal,
1 with cephalic fold omphalocele). Less frequent path-
ologies were meningomyelocele (1 patient) and epider-
molysis bullosa (1 patient with simplex type, 2 with
junctional generalized severe type). All patients in the
non-isolated ACC group showed a high risk of other as-
sociated congenital anomalies. Gastrointestinal malfor-
mations were the most frequent (29% congenital
malformation of intestinal fixation, 19% congenital atre-
sia and stenosis of intestine, 14% Meckel’s diverticulum),
followed by 33% cardiac, 19% musculoskeletal, 19% geni-
tourinary (epispadias/hypospadias), and 5% involving the
central nervous system. Congenital inguinal hernia at ad-
mission was present in 19% newborns. In this study, no
specific genetic alterations have been identified with gas-
troschisis, but omphalocele was associated with chromo-
somal anomalies in 9.5% (Trisomy 18, derivative Y
chromosome) and monogenic alterations in 9.5% of
cases (Noonan syndrome, Beckwith-Wiedemann syn-
drome). In both patients with generalized severe junc-
tional epidermolysis bullosa (JEB-gen sev) we found
homozygote known mutations in LAMC2 gene (c.1A > G
and c.667C > T, respectively).
Sixteen patients with primary hernia reduction and de-
fect closure required assisted mechanical ventilation, naso-
gastric decompression and sustained intravenous fluids.
Additional lateral relaxing incisions in the fascia were per-
formed for primary closure in the case of meningomyelo-
cele. Different operative techniques were used to stretch
the abdominal wall in preparation for primary closure in
abdominal wall defects. Concomitant gastrointestinal mal-
formations were treated, in three patients by temporary
enterostomy. In two patients a Silastic silo for gradual re-
duction of intestine was placed and subsequent defect
closure by soft tissue patches (Gore-Tex) was performed.
In two patients with gastroschisis, after primary closure of
wall defect, an emergent decompression by silo was re-
quired owing to abdominal compartment syndrome.
Analyzing isolated and non-isolated ACC, we found
similarities in maternal variables and some differences in
anthropometric values, clinical features and short-term
prognosis (Table 2).
Table 2 Anthropometric and clinical features of ACC at birth and clinical outcome at 1-month Follow-up, with p values
ACC1
(n = 16)
Non-isolated ACC
(n = 21)
Mean SD Median IQR Mean SD Median IQR p
Mother’s age (years) 31.0 3.7 31 5 29.9 9.5 29 8.5 0.42610
Gestational age (weeks) 38+ 3 2+ 2 39 2 36+ 6 2+ 5 37+ 3 3 0.07217
Parity 1.5 0.5 1.5 1 1.6 0.6 1.5 1 0.88460
Gender (F/M) 1 0.62 0.51950
Cesarean section (%) 69 67 0.74750
Prematurity (%) 18.8 47.6 0.09118
Prematurity < 34 weeks (%) 6.3 19.0 0.36410
Weight (g) 3023 403 3015 522.5 2442 697 2645 1098 0.00903
Weight centile 42.3 24.9 37 37 24.3 24.0 13 23.5 0.01761
SGA (< 10° centile, %) 6.3 33.3 0.03923
Length centile 32.8 25.6 36 40 21.1 22.9 14.5 28.3 0.23630
Head circumference centile 42.3 26.4 37 28.5 42.7 35.3 46 48 0.89670
Apgar 1’ 8.9 1.0 9 0.5 7.3 1.6 8 1.5 0.00057
Apgar 5’ 9.5 0.8 10 1.0 9.0 1.1 9 2 0.10580
Glycemia at birth (mg/dl) 64.4 15.7 62 27 96 17 101 16.5 0.05271
Calcemia (mg/dl) 9.4 1.1 9.6 1.3 8.7 1.2 8.7 2.3 0.16530
Parenteral nutrition (days) 0.5 1.9 0 0 28.9 41.2 17 24 0.00004
Hospital stay (days) 8.8 6.5 7.5 8.8 41.3 37.5 38 38 0.00490
Good outcome (%) 100 67 0.01241
Abbreviations: ACC aplasia cutis congenita, SGA small for gestational age. Significant differences are in bold
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Discussion
In this study we evaluated prevalence, comorbidities,
treatment and outcome of newborns with various forms
of ACC. Prevalence of ACC1 was about 3-fold higher
than previously reported [9], probably because this study
was based on strict medical records review and was not
limited to Hospital discharge forms, that could not in-
clude small ACC in wellbeing newborns. Unlike previous
reports, we did not exclude dominant forms of isolated
ACC [9]. The prognosis of self-healing scalp lesions, in-
cluding the larger ones, was excellent. We do not con-
firm in our patients the previously high mortality rate
among patients with ACC1 [7].
In our sample the predominance of non-isolated ACC,
in inborn infants too, is correlated to the high level of
specialization in the intensive prenatal, neonatal and sur-
gical management of patients affected by congenital
anomalies and syndromes characterizing our Depart-
ment. The retrospective design allowed data collection
with known outcome and prevalence estimation. Inci-
dence and prevalence were unexpectedly high, probably
because incidence data in previous studies refer to works
published prior to the adoption of the latest classifica-
tion which includes nine clinical variants, and not de-
tailed since ACC has been considered as a unique
clinical entity.
Analyzing isolated and non-isolated ACC, we found
some similarities. Maternal variables including, age,
pathological conditions and no assumption of drugs po-
tentially affecting the fetus were similar, and no statisti-
cally significant difference between groups were found
for sex, neonatal length and head circumference in rela-
tion to gestational age.
On the other hand, we found some differences in
other anthropometric values and clinical features.
Higher birth weight centile, though lower than refer-
ence population, being adequate for gestational age
(AGA) and normal Apgar score characterizing ACC1 re-
sulted associated to the rapid tissue regeneration, ob-
served in all patients including the cases with larger
scalp defect. Furthermore, in this group we did not ob-
serve neonatal infections since rigorous infection-control
practices, along with gentle cleansing and application of
topical antibiotics, have been applied in all patients.
We registered a relative lower “care burden” measured
as total parenteral nutrition, assisted mechanical ventila-
tion, surgical intervention and length of hospital stay, as
in previous report on more severe, but isolated malfor-
mation [10].
Taking into account the etiology of ACC1, since in
our cases we did not identify any antiphospholipid anti-
body syndrome or thrombophilia during pregnancy, we
could exclude a pathogenic role of vascular disruption
or placental infarcts [11]. In our institution drug
assumption is based on self-reporting and we do not
undergo toxicological tests until the neonatal neurobe-
havioral examination is normal, nevertheless we cannot
exclude that in some cases drug assumption have been
undetected.
In case of familial recurrence of ACC1, an autosomal
dominant transmission was plausible as reported in pre-
vious studies [1]. In two patients, a-CGH showed the in-
volvement of genes that could interfere with epidermal
development. The most relevant finding has been the as-
sociation with NTM (neurotrimin) gene, recently related
not only to neural cell development and survival but also
to skin cell adhesion and increased risk of melanoma
[12].
The normal neuro-behavioral assessment and cerebral
US at discharge, reported in ACC1, have a positive prog-
nostic value in terms of normal development.
Neonatal mortality rate has not been reported previ-
ously in non-isolated ACC group.
In non-isolated ACC we observed an increased gly-
cemic value at birth attributable to antenatal corticoster-
oid treatment for the prevention of respiratory distress,
owing to the relative high rate of prematurity below 34
weeks gestation.
Non-isolated ACC, in relation to concomitant con-
genital anomalies and higher prematurity rate, showed
more surgical and medical complications along with the
risk of death. Specifically, newborns with ACC4 were
characterized by the frequent necessity of abdominal
wall defect repair, responsible for the occurrence of an
abdominal compartment syndrome [13] carrying an in-
creased risk of multiorgan failure and neonatal death.
The two patients with ACC6 presenting with JEB-gen
sev and one patient with omphalocele, despite intense
treatment performed in specialized centers, died at 3
months of age, confirming the ominous prognosis re-
ported in scientific literature [14].
Although, to our knowledge, a prolonged follow-up in
ACC1 on possible skin tumorigenesis has not been per-
formed, a prominent tumor suppression role has been
demonstrated in case of increased p21 levels related to
BMS1 mutations, and responsible for prominent hyper-
trophic scar formation observed in ACC1 [5, 15, 16].
Conclusions
The newborn affected by ACC should be carefully exam-
ined in order to exclude concomitant other congenital
malformations affecting primarily ectoderm-derived tis-
sues and organs. Family should be oriented toward iden-
tification of other family members affected by similar
pathology, while obstetric history should exclude initial
multiple pregnancy with death of a co-twin, placental
anomalies and drug assumption. Since birth standard in-
fection control measures should be applied.
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Individualized neonatal care and a family centered
model of assistance should be developed in case of ACC
concomitant to other severe malformations or JEB-gen
sev in relation also to the emotional difficulties the par-
ents must face in front of their child’s potential death.
Once a final molecular-genetic diagnosis has been
achieved, family should receive genetic counseling re-
garding the risk of recurrence.
Abbreviations
ACC: Aplasia cutis congenita; a-CGH: Array-comparative genomic
hybridization; JEB-gen sev: Generalized severe junctional epidermolysis
bullosa
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